Gene BioHealth, a Shenzhen-based innovative enterprise with tumor early screening IVD technology, recently contracted with West Bay National Major Instrument Science Park to settle its Zhongshan company in Tsuihang New District.

Gene BioHealth is a biotech enterprise focusing on in vitro diagnosis (IVD) technology and human health undertakings. It was founded in 2013 by returned scientist Yu Haoyang. It can provide complete technology solutions, reagents, instruments and services in the fields of tumor diagnosis, instant detection and AI cancer staging.

Biomedicine is one of the key pillar industries of Tsuihang New District. Currently, THND has gathered such top biomedicine-related research institutes and innovative R&D platforms as the CAS Zhongshan Institute for Drug Discovery, Biomedical Intelligence Innovation Center, West Bay National Major Instrument Science Park, and Akeso Biopharma Bay Area Science Park.